title: Efficacy of imatinib mesylate in a case of Churg-Strauss syndrome: evidence for the pathogenic role of a tyrosine kinase?
authors.affiliation: Department of Internal Medicine, Hospital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France. laurence.josselin@sat.aphp.fr.
authors.forename: Laurence
authors.initials: L
authors.lastname: Josselin-Mahr
authors.forename: Anabelle
authors.initials: A
authors.lastname: Werbrouck-Chiraux
authors.forename: Laurent
authors.initials: L
authors.lastname: Garderet
authors.forename: Jean
authors.initials: J
authors.lastname: Cabane
mesh_terms: D000328:Adult; D001549:Benzamides / Q000627:therapeutic use*; D006502:Budd-Chiari Syndrome / Q000453:epidemiology; D015267:Churg-Strauss Syndrome / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology*; D015897:Comorbidity; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000502:physiology*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases